| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GPL21290
|
Haoyan Chen
|
|||||||
| GSM3732880 |
DLD-1 Cell line treated by ETBF for 2 hours-replicate 3
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732881 |
DLD-1 Cell line treated by ETBF for 6 hours-replicate 1
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732882 |
DLD-1 Cell line treated by ETBF for 6 hours-replicate 2
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732883 |
DLD-1 Cell line treated by ETBF for 6 hours-replicate 3
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732884 |
Normal Control-replicate 1
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732885 |
Normal Control-replicate 2
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732886 |
Normal Control-replicate 3
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732887 |
Normal Control-replicate 4
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732888 |
DLD-1 Cell line treated by E-Coli-replicate 1
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732889 |
DLD-1 Cell line treated by E-Coli-replicate 2
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3732890 |
DLD-1 Cell line treated by E-Coli-replicate 3
|
SRA | 1 |
|
Haoyan Chen | Apr 13, 2020 | |||
| GSM3895624 |
Control siRNA (c-myc antibody treatment)
|
SRA | 1 |
|
Haoyan Chen | Jul 08, 2019 | |||
| GSM3895625 |
lncRNA-AF339830 siRNA (c-myc antibody treatment)
|
SRA | 1 |
|
Haoyan Chen | Jul 08, 2019 | |||
| GSM4087746 |
Control 1
|
SRA | 1 |
|
Haoyan Chen | Sep 01, 2022 | |||
| GSM4087747 |
Control 2
|
SRA | 1 |
|
Haoyan Chen | Sep 01, 2022 | |||
| GSM4087748 |
Control 3
|
SRA | 1 |
|
Haoyan Chen | Sep 01, 2022 | |||
| GSM4087749 |
TGFB treatment 1
|
SRA | 1 |
|
Haoyan Chen | Sep 01, 2022 | |||
| GSM4087750 |
TGFB treatment 2
|
SRA | 1 |
|
Haoyan Chen | Sep 01, 2022 | |||
| GSM4087751 |
TGFB treatment 3
|
SRA | 1 |
|
Haoyan Chen | Sep 01, 2022 | |||
| GSM4888901 |
HCT116 Cell line treated by ETBF for 6 hours-replicate 1
|
SRA | 1 |
|
Haoyan Chen | Nov 08, 2023 |
